healthcare-thumbnail.png

Carnitine Supplements Market Research Report – Segmented By Process (Chemical Synthesis, Bioprocess); By Product (Food & Pharma Grade, Feed Grade); By Application (Animal Feed, Healthcare Products, Functional Food & Beverages, Medicines); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)

Global Carnitine Supplements Market Size (2024 - 2030)

The Global Carnitine Supplementation Market was valued at USD 167.01 Billion and is projected to reach a market size of USD 235.00 Billion by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 5%.

Carnitine Supplementation Market

Industry Overview

Increased concern about health among the older population, together with a growing preference for preventive healthcare, is expected to drive growth in the worldwide L-carnitine supplements market from 2023 - 2030. L-carnitine is thought to be useful in improving post-exercise recovery in the elderly. This substance also aids in the improvement of mental performance and the reduction of fatigue in the elderly population. Furthermore, it lowers the risk of skeletal deterioration, which affects the majority of the aging population. These supplements aid in the reduction of muscle breakdown, the promotion of healthy aging, and the preservation of lean muscle mass. Because of these advantages, the worldwide L-carnitine supplements market is expected to expand significantly in the coming years.

L-carnitine products are also used to provide supplements to those who have low amounts of natural L-carnitine. L-carnitine deficiency is expected to be caused by a variety of reasons, including particular medical illnesses such as skeletal myopathies, the use of specific medicines, and hereditary abnormalities. These factors are anticipated to drive demand for L-carnitine supplements in the next years.

Rabie et al. discovered that a meal enriched with L-carnitine ranging from 20 to 60 mg/kg increased the growth performance of broiler chickens. Similarly, supplementing L-carnitine in the diet with animal fat at 300 mg/kg increased body weight gain, feed intake, and feed conversion ratio in broiler chickens. Furthermore, rising consumption of functional foods is expected to drive the Global L-Carnitine Supplements Market forward. However, product-related side effects and essential manufacturing processes may stymie market growth throughout the forecast period of 2023 - 2030.

Impact of Covid-19 on the Industry

The COVID 19 epidemic, which began in early 2020, drastically impacted the supply chain, retail distribution, and consumer behavior for a wide range of products and services throughout the world. However, the demand for L-carnitine grew during the pandemic because of the increasing customer desire for health and wellness products that minimize the risk of cardiovascular disease.

Furthermore, researchers at the MRC Integrative Epidemiology Unit (IEU) at Bristol Medical School in the United Kingdom determined that L-carnitine and its derivatives, such as acetyl-carnitine, give significant protection against severe COVID 19 individuals. According to the study, increasing carnitine levels in the blood decreases the incidence of severe COVID-19 by 40%. Because large, randomized trials are expensive and time-consuming, the study used a small sample size. However, such a great outcome for L-carnitine in severe COVID 19 patients is likely to boost its demand in a shorter period.

Market Drivers

Increasing demand in the fitness industry will drive the market growth

L-carnitine is one of the most recommended fat loss supplements in the fitness industry. The helps the body to prioritize long-chained fatty acid as a primary source of energy for the body. This helps the people who work out in the gym to gain muscles to preserve muscle while being on a fat loss program.

 Increasing trust in supplementation will drive the consumer demand

With the rising adoption of new legislation governing supplement markets in several nations, industry participants are finding it difficult to tailor their marketing strategy to each country's restrictions. For a larger client base and a greater worldwide presence, such players prioritize the separation of nutritional declarations and product components by the standards and consumer expectations. Mergers and acquisitions, it has contributed to a concentration on establishing new product portfolio lines, therefore preserving a dependable, high-quality raw material supply.

Market Restraints

Usage of carnitine has some side effects

Many studies have shown that using carnitine for an excessive period can result in nausea, vomiting, stomach distress, diarrhea, heartburn, etc. This could be a significant restraint on the market growth of carnitine supplementation.

CARNITINE SUPPLEMENTS MARKET REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2023 - 2030

Base Year

2023

Forecast Period

2024 - 2030

CAGR

5%

Segments Covered

By Process,  Product, Application,  and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regional Scope

North America, Europe, APAC, Latin America, Middle East & Africa

Key Companies Profiled

Lonza, Northeast Pharmaceutical Group Co., Ltd. (NEPG), Biosint S.p.A., Cayman Chemical, Merck KGaA, Tokyo Chemical Industry Co., Ltd., Ceva, Kaiyuan Hengtai Nutrition Co., Ltd., ChengDa PharmaCeuticals Co., Ltd., Huanggang Huayang Pharmaceutical Co. Ltd., HuBeiYuancheng SaichuangTechnology Co, .Ltd

This research report on the global carnitine supplementation market has been segmented and sub-segmented based on, Geography & region.

Global Carnitine Supplementation Market- By Process

  • Chemical Synthesis
  • Bioprocess

In 2020, the bioprocess segment led the market with a revenue share of more than 76.0 percent. The increasing commercial demand for L-carnitine has prompted producers to upgrade their procedures to increase manufacturing yield. Biological processes that use microbes and enzymes are inherently asymmetric and have high output yields.

The most common method for producing L-carnitine with the highest yield in a bioprocess is based on the biotransformation of achiral precursors such as -butyrobetaine, crotonobetaine, and 3-dehydrocarnitine, or racemic combinations such as D, L-carnitinamide, D, L-acyl carnitine, and D, L-carnitine. Escherichia coli, Proteus mirabilis, Acinetobacter lwoffii, Bacillus, Penicillium, and Rhizopus are among the bacteria found.

Because of its capacity to generate L-carnitine on an industrial scale, the chemical synthesis approach is gradually gaining traction. For the production of L-carnitine, numerous chemical approaches are accessible, including asymmetric synthesis, chemical multi-step racemization, enzymatic techniques, resolution via diastereomeric derivatives, and synthesis employing chiral materials. Many of these processes, however, are impractical for industrial-scale manufacturing because they entail several time-consuming phases.

One of the most common chemical synthesis procedures for producing L-carnitine is chemical multistep racemization, which produces D-carnitine racemic mixture as a by-product. The method typically begins with raw ingredients such as epichlorohydrin and trimethylamine, followed by fractioned crystallization to separate the mixture.

Global Carnitine Supplementation Market- By Product

  • Food & Pharma Grade
  • Feed Grade

In 2020, the food and pharmaceutical grade category led the market, accounting for more than 78.0 percent of total revenue. L-carnitine is largely utilized for human ingestion in a variety of applications such as healthy aging, male fertility, baby feeding, weight control, and post-exercise recovery.

Even though the product is naturally found in specific foods such as meat, avocado, and beans, a particular level of L-carnitine is required to maintain an acceptable level in the body based on age, nutrition, and other factors. The substance is absorbed in a variety of ways, including orally via nutritional supplements, pharmaceuticals, functional food and drinks, and injections. It is crucial in helping the healing process following physical exertion.

Feed quality L-carnitine is a common element in animal medicines and animal feed. It is a vital component of animal energy metabolism and provides several benefits to diverse species, including weight control and good heart and liver function. Feed grade is widely utilized in the cattle sector, pet food makers, and racing animal food companies. The ingredient is commonly used in dry feeds and treats for cats and dogs. It is also utilized as an antioxidant and to aid in the rehabilitation of working dogs' muscles. Feed grade is mostly utilized in pet health supplements for hazards associated with heart disease, particularly in situations of dilated cardiomyopathy.

Global Carnitine Supplementation Market- By Application

  • Animal Feed
  • Healthcare Products
  • Functional Food & Beverages
  • Medicines

In 2020, healthcare items dominated the market, accounting for more than 34.0 percent of total sales. L-carnitine is frequently utilized in a variety of healthcare goods, including weight reduction and stamina supplements. The dietary supplement market is estimated to reach USD 272.4 billion by 2028, owing to rising obesity incidence, increased consumer knowledge about personal health and wellness, changing lifestyles, and expanding spending capacity. Over the projection period, the fast development of the dietary supplement business is likely to provide profitable prospects for manufacturers.

L-carnitine is a micronutrient that is important for the growth of many animal species, including poultry, swine, cows and calves, horses, and companion animals. Dietary L-carnitine supplementation improves this animal nutrition status by providing appropriate dietary energy and protein.

L-carnitine supplementation in animal diets promotes body weight gain, feed intake, and feed conversion in broiler chicken. L-carnitine supplementation in feed promotes energy consumption and fatty acid utilization, which may improve live weight growth and feed conversion efficiency in chicken.

Globally, the health-conscious population has been turning away from carbonated beverages and toward functional beverages, as seen by the recent increasing introduction of functional beverages such as kombucha, relaxation beverages, and botanical ingredients-based beverages.

Beverage producers are increasingly capitalizing on altering customer behavior by introducing new drinks enhanced with ingredients like L-carnitine. For example, LIFEAID Beverage Co.'s new version of FOCUSAID beverage with L-carnitine as a functional component will be available in March 2020. L-expansion carnitine in the functional food and beverage industry is likely to fuel the product's growth throughout the forecast period.

Global Carnitine Supplementation Market- By Geography & Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

North America led the L-carnitine market, accounting for more than 37.0 percent of sales in 2020. With the emergence of a health-conscious customer base in the area over the last decade, the functional food and beverage industry has witnessed tremendous growth in North America.

L-carnitine is an important component in the treatment and prevention of a variety of disorders, making it an appealing functional food and beverage ingredient. The improved level of energy and stamina, as well as other health advantages, has shifted consumer preferences toward functional foods and beverages containing L-carnitine. The rising preference for L-carnitine supplements among North American consumers is likely to drive market expansion during the forecast period.

L-carnitine supplements are also utilized in the treatment of obesity for weight management. Mexico and the United States have the world's most obese populations, which has led to a surge in the use of weight-loss supplements. This is projected to fuel the region's market throughout the predicted period.

The nutraceutical sector in Europe is predicted to rise as people buy supplements as a preventive measure for health problems. Furthermore, due to the negative side effects of drugs, people choose herbal products over pharmaceuticals. The increased adoption of nutraceuticals to promote health without posing any possible health risks is likely to drive market expansion during the forecast period.

Global Carnitine Supplementation Market- By Companies

  1. Lonza
  2. Northeast Pharmaceutical Group Co., Ltd. (NEPG)
  3. Biosint S.p.A.
  4. Cayman Chemical
  5. Merck KGaA
  6. Tokyo Chemical Industry Co., Ltd.
  7. Ceva
  8. Kaiyuan Hengtai Nutrition Co., Ltd.
  9. ChengDa PharmaCeuticals Co., Ltd.
  10. Huanggang Huayang Pharmaceutical Co. Ltd.
  11. HuBeiYuancheng SaichuangTechnology Co, .Ltd

NOTABLE HAPPENINGS IN THE GLOBAL CARNITINE SUPPLEMENTATION MARKET IN THE RECENT PAST:

  • Product Launch: - In 2022, Applied Nutrition, a sports nutrition firm located in the United Kingdom, announced the release of its new L-Carnitine sports drink. Carni-Tone is the company's first flavored spring water, and it expands the company's ready-to-drink (RTD) product line. It is also the company's first L-Carnitine (a chemical that aids in energy metabolism) RTD beverage, having been in development since early last year.
  • Product Launch: - In 2019, FitLife Brands' (OTC Pink: FTLF) iSatori subsidiary debuted its L-Carnitine fat reduction liquid keto drink mix this week in 3,700 Walmart locations across the United States. L-Carnitine is an amino acid that aids the body's conversion of fat into fuel and is essential for energy generation. The liquid L-Carnitine drink mix from iSatori is a delicious and nutritious approach to help convert fat into energy that includes no calories, stimulants, or gluten.

 

Chapter 1. GLOBAL CARNITINE SUPPLEMENTATION MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. GLOBAL CARNITINE SUPPLEMENTATION MARKET – Executive Summary

2.1. Market Size & Forecast – (2024 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2024 - 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. GLOBAL CARNITINE SUPPLEMENTATION MARKET – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. GLOBAL CARNITINE SUPPLEMENTATION MARKET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. GLOBAL CARNITINE SUPPLEMENTATION MARKET Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. GLOBAL CARNITINE SUPPLEMENTATION MARKET – By  Process

6.1. Chemical Synthesis

6.2. Bioprocess

Chapter 7.  GLOBAL CARNITINE SUPPLEMENTATION MARKET – By Product

7.1. Food & Pharma Grade

7.2. Feed Grade

Chapter 8.  GLOBAL CARNITINE SUPPLEMENTATION MARKET – By Application

8.1. Animal Feed

8.2. Healthcare Products

8.3. Functional Food & Beverages

8.4. Medicines

Chapter 9.  GLOBAL CARNITINE SUPPLEMENTATION MARKET – By Region

9.1. North America

9.2. Europe

9.3. The Asia Pacific

9.4. Latin America

9.5. The Middle East and Africa

Chapter 10.  GLOBAL CARNITINE SUPPLEMENTATION MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Lonza

10.2. Northeast Pharmaceutical Group Co., Ltd. (NEPG)

10.3. Biosint S.p.A.

10.4. Cayman Chemical

10.5. Merck KGaA

10.6. Tokyo Chemical Industry Co., Ltd.

10.7. Ceva

10.8. Kaiyuan Hengtai Nutrition Co., Ltd.

10.9. ChengDa PharmaCeuticals Co., Ltd.

10.10. Huanggang Huayang Pharmaceutical Co. Ltd.

10.11. HuBeiYuancheng SaichuangTechnology Co, .Ltd

 

Download Sample

The field with (*) is required.

Choose License Type

$

2500

$

4250

$

5250

$

6900

Analyst Support

Every order comes with Analyst Support.

Customization

We offer customization to cater your needs to fullest.

Verified Analysis

We value integrity, quality and authenticity the most.